(Q35917480)

11 August 2017

1 reference

title

Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy (English)

1 reference

11 August 2017

0 references

Karl S Peggs

1

1 reference

11 August 2017

language of work or name

1 reference

1 August 2004

1 reference

Expert Review of Anti-infective Therapy

11 August 2017

published in

1 reference

11 August 2017

volume

2

1 reference

11 August 2017

issue

4

1 reference

11 August 2017

page(s)

559-573

1 reference

Clinical aspects and management of cytomegalovirus infection

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

A Prospective Analysis of Interstitial Pneumonia and Opportunistic Viral Infection among Recipients of Allogeneic Bone Marrow Grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Reduced risk of recurrent leukaemia in bone marrow transplant recipients after cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

The human cytomegalovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

NK cells and NKT cells in innate defense against viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Viral subversion of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Human cytomegalovirus and natural killer-mediated surveillance of HLA class I expression: a paradigm of host-pathogen adaptation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Viral mimicry of cytokines, chemokines and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Rapid detection of cytomegalovirus infection in transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Quantitation of human cytomegalovirus (HCMV) DNA in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Predictive value of cytomegalovirus (CMV) antigenemia and digene hybrid capture DNA assays for CMV disease in human immunodeficiency virus-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Use of CMV transcripts for monitoring of CMV infections in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Clinical trials with CMV-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Optimization of DNA immunization against human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Severe herpesvirus infections in an adolescent without natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Cytomegalovirus‐Specific Cellular Immune Responses and Viremia in Recipients of Allogeneic Stem Cell Transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.559

21 January 2018

Identifiers

DOI

10.1586/14787210.2.4.559

1 reference

11 August 2017

1 reference